Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
Intrinsic Value
Dr. Sulaiman Al-Habib Medical Services Group Company is a Saudi Arabia-based company engaged in health care sector. [ Read More ]
The intrinsic value of one
Dr Sulaiman Al-Habib Medical Services Group Co
stock under the Base Case scenario is
192.56
SAR.
Compared to the current market price of 315.4 SAR,
Dr Sulaiman Al-Habib Medical Services Group Co
is
Overvalued by 39%.
Dr Sulaiman Al-Habib Medical Services Group Co's market capitalization is 110.4B SAR.
Dr Sulaiman Al-Habib Medical Services Group Co stock price is 315.4 SAR.
Dr Sulaiman Al-Habib Medical Services Group Co stock (192.56 SAR) is 39% less than its price (315.4 SAR).
Dr Sulaiman Al-Habib Medical Services Group Co stock (57.43 SAR) is 82% less than its price (315.4 SAR). Open DCF Valuation
Dr Sulaiman Al-Habib Medical Services Group Co stock price (315.4 SAR) is 4% less than its Relative Value (327.7 SAR). Open Relative Valuation
Dr Sulaiman Al-Habib Medical Services Group Co has downside potential of 7% compared to the average analyst price target.
Open Wall St Estimates
Dr Sulaiman Al-Habib Medical Services Group Co has positive Net Debt. This means that the company has more debt (5B SAR) than cash and short-term investments (3B SAR).
Dr Sulaiman Al-Habib Medical Services Group Co's ROIC (Return on Invested Capital) has increased in the last 3 years from 17% to 20%.
Dr Sulaiman Al-Habib Medical Services Group Co's Revenue has grown by 14% over the past 12 months.
Dr Sulaiman Al-Habib Medical Services Group Co's short-term assets (4B SAR) exceed its short-term liabilties (3B SAR).
Dr Sulaiman Al-Habib Medical Services Group Co's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 20%.
Dr Sulaiman Al-Habib Medical Services Group Co's ROE (Return on Equity) has increased in the last 3 years from 23% to 33%.
Dr Sulaiman Al-Habib Medical Services Group Co has positive Operating Income for the last twelve months.
Dr Sulaiman Al-Habib Medical Services Group Co has positive Net Income for the last twelve months.
Dr Sulaiman Al-Habib Medical Services Group Co's Revenue is forecast to grow at a rate of 19% per year over the next 3 years.
Dr Sulaiman Al-Habib Medical Services Group Co's Revenue has been growing by 18% per year for the last 3 years.
Dr Sulaiman Al-Habib Medical Services Group Co's D/E (Debt to Equity) is very low and is equal to 0.78.
Dr Sulaiman Al-Habib Medical Services Group Co has positive three-year average ROIC (Return on Invested Capital): 19%. The company is efficient at using invested capital to generate operating income.
Dr Sulaiman Al-Habib Medical Services Group Co's long-term assets (16B SAR) exceed its long-term liabilties (9B SAR).
Dr Sulaiman Al-Habib Medical Services Group Co's ROE (Return on Equity) for the past 12 months is very high and is equal to 33%.
Dr Sulaiman Al-Habib Medical Services Group Co has positive Gross Profit for the last twelve months.
Dr Sulaiman Al-Habib Medical Services Group Co has negative Free Cash Flow for the last twelve months.
Dr Sulaiman Al-Habib Medical Services Group Co has very high three-year average ROE (Return on Equity): 28%. The company is very efficient at transforming stockholders' equity into net income.
Dr Sulaiman Al-Habib Medical Services Group Co's Altman Z-Score is very high and is equal to 7.57.
Valuation Backtest
Dr Sulaiman Al-Habib Medical Services Group Co
Run backtest to discover the historical profit from buying and selling
Dr Sulaiman Al-Habib Medical Services Group Co
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Dr Sulaiman Al-Habib Medical Services Group Co
Balance Sheet Decomposition
Dr Sulaiman Al-Habib Medical Services Group Co
| Current Assets | 4.1B |
| Cash & Short-Term Investments | 2.6B |
| Receivables | 703.1m |
| Other Current Assets | 814.3m |
| Non-Current Assets | 11.7B |
| Long-Term Investments | 497.6m |
| PP&E | 11.2B |
| Current Liabilities | 3.3B |
| Accounts Payable | 1.3B |
| Accrued Liabilities | 1.7B |
| Other Current Liabilities | 315.3m |
| Non-Current Liabilities | 6B |
| Long-Term Debt | 5B |
| Other Non-Current Liabilities | 967.9m |
Earnings Waterfall
Dr Sulaiman Al-Habib Medical Services Group Co
|
Revenue
|
9.5B
SAR
|
|
Cost of Revenue
|
-6.2B
SAR
|
|
Gross Profit
|
3.3B
SAR
|
|
Operating Expenses
|
-1.2B
SAR
|
|
Operating Income
|
2.1B
SAR
|
|
Other Expenses
|
-49.6m
SAR
|
|
Net Income
|
2B
SAR
|
Free Cash Flow Analysis
Dr Sulaiman Al-Habib Medical Services Group Co
Profitability Score
Profitability Due Diligence
Dr Sulaiman Al-Habib Medical Services Group Co's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Dr Sulaiman Al-Habib Medical Services Group Co's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dr Sulaiman Al-Habib Medical Services Group Co's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Dr Sulaiman Al-Habib Medical Services Group Co's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dr Sulaiman Al-Habib Medical Services Group Co
According to Wall Street analysts, the average 1-year price target for
Dr Sulaiman Al-Habib Medical Services Group Co
is 293.01 SAR
with a low forecast of 202 SAR and a high forecast of 346.5 SAR.
Shareholder Return
Price
Dr Sulaiman Al-Habib Medical Services Group Co
| Average Annual Return | 64.11% |
| Standard Deviation of Annual Returns | 32.71% |
| Max Drawdown | -9% |
| Market Capitalization | 110.4B SAR |
| Shares Outstanding | 350 000 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Dr Sulaiman Al-Habib Medical Services Group Co
Country
Industry
Market Cap
Dividend Yield
Description
Dr. Sulaiman Al-Habib Medical Services Group Company is a Saudi Arabia-based company engaged in health care sector. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2020-02-26. The firm operates through it's subsidiaries in three segments: Hospitals, Pharmacies and Other. The Hospital segment is engaged in setting up, managing and operating hospitals, medical facilities, pharmacies and medical diagnostic and radiological laboratories. The Pharmacies segment operates Al Habib Pharmacies, Middle East Pharmacies Company and Afia Pharmacies Company. The Other segments include management and operations services for third party, home healthcare service, intensive care units, ambulatory transportation, facility maintenance services information technology and systems services, cloud solutions, among others. The firm also provides import and export, wholesale and retail sale of medicines, medical and herbal products, cosmetics, medical devices and equipment.
Officers
The intrinsic value of one
Dr Sulaiman Al-Habib Medical Services Group Co
stock under the Base Case scenario is
192.56
SAR.
Compared to the current market price of 315.4 SAR,
Dr Sulaiman Al-Habib Medical Services Group Co
is
Overvalued by 39%.
You don't have any saved screeners yet
